| Literature DB >> 34661665 |
Masatoshi Nishimoto1, Miho Murashima1,2, Maiko Kokubu3, Masaru Matsui1,3, Masahiro Eriguchi1, Ken-Ichi Samejima1, Yasuhiro Akai1, Kazuhiko Tsuruya1.
Abstract
Importance: The Simple Postoperative AKI Risk (SPARK) index is a prediction model for postoperative acute kidney injury (PO-AKI) in patients undergoing noncardiac surgery. External validation has not been performed. Objective: To externally validate the SPARK index. Design, Setting, and Participants: This single-center retrospective cohort study included adults who underwent noncardiac surgery under general anesthesia from 2007 to 2011. Those with obstetric or urological surgery, estimated glomerular filtration rate (eGFR) of less than 15 mL/min/1.73 m2, preoperative dialysis, or an expected surgical duration of less than 1 hour were excluded. The study was conducted at Nara Medical University Hospital. Data analysis was conducted from January to July 2021. Exposures: Risk factors for AKI included in SPARK index. Main Outcomes And Measures: PO-AKI, defined as an increase in serum creatinine of at least 0.3 mg/dL within 48 hours or 150% compared with preoperative baseline value or urine output of less than 0.5 mL/kg/h for at least 6 hours within 1 week after surgery, and critical AKI, defined as either AKI stage 2 or greater and/or any AKI connected to postoperative death or requiring kidney replacement therapy before discharge. The discrimination and calibration of the SPARK index were examined with area under the receiver operating characteristic curves (AUC) and calibration plots, respectively.Entities:
Mesh:
Year: 2021 PMID: 34661665 PMCID: PMC8524308 DOI: 10.1001/jamanetworkopen.2021.27362
Source DB: PubMed Journal: JAMA Netw Open ISSN: 2574-3805
Figure 1. Study Flowchart
Participant Characteristics
| Characteristic | Participants, No. (%) (N = 5135) |
|---|---|
| Age, y | |
| Median (IQR) | 63 (50-73) |
| <40 | 746 (14.5) |
| ≥40 to <60 | 1326 (25.8) |
| ≥60 to <80 | 2681 (52.2) |
| ≥80 | 382 (7.4) |
| Men | 2410 (46.9) |
| Women | 2725 (53.1) |
| Body mass index, median (IQR) | 22.5 (20.3-24.9) |
| Preexisting comorbidities | |
| Heart disease | 298 (5.8) |
| Hypertension | 1817 (35.4) |
| Diabetes | 802 (15.6) |
| Types of surgery | |
| General | 4323 (84.2) |
| Urologic | 0 |
| Obstetrics | 0 |
| Pelvic or major joint surgery | 812 (15.8) |
| Surgery duration, median (IQR), h | 2.8 (1.9-4.1) |
| Expected surgery duration, median (IQR), h | 3.0 (2.5-5.0) |
| Anesthesia type | |
| General | 5135 (100) |
| Nongeneral | 0 |
| Emergency surgery | 292 (5.7) |
| Blood pressure before surgery, median (IQR), mm Hg | |
| Systolic | 140 (125-160) |
| Diastolic | 80 (70-85) |
| RAAS blockade use | 963 (18.8) |
| Laboratory findings | |
| eGFR, median (IQR), mL/min/1.73 m2 | 78.2 (65.6-92.2) |
| CKD stage | |
| None, 1, or 2 (eGFR ≥60 mL/min/1.73 m2) | 4278 (83.3) |
| 3A (eGFR ≥45 to <60 mL/min/1.73 m2) | 590 (11.5) |
| 3B (eGFR ≥30 to <45 mL/min/1.73 m2) | 184 (3.6) |
| 4 (eGFR ≥15 to <30 mL/min/1.73 m2) | 83 (1.6) |
| Dipstick albuminuria | 470 (9.2) |
| White blood cell count, median (IQR), /μL | 6000 (4900-7500) |
| Hemoglobin, mean (SD), g/dL | 12.8 (1.9) |
| Anemia | 1902 (37.0) |
| Platelet count, median (IQR), 103/μL | 231 (190-280) |
| Albumin, mean (SD), g/dL | 4.2 (0.5) |
| Hypoalbuminemia | 470 (9.2) |
| Sodium, mean (SD), mEq/L | 141 (2.9) |
| Hyponatremia | 149 (2.9) |
| Potassium, mean (SD), mEq/L | 4.1 (0.4) |
Abbreviations: CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; RAAS, renin-angiotensin-aldosterone system.
SI conversion factors: To convert white blood cell count to ×109 per liter, multiply by 0.001; hemoglobin to grams per liter, multiply by 10.0; platelets to ×109 per liter, multiply 1.0; albumin to grams per liter, multiply 10.0; sodium and potassium to millimoles per liter, multiply 1.0.
Body mass index was calculated as weight in kilograms divided by height in meters squared.
Heart disease was defined as the history of heart failure or coronary artery disease (angina or myocardial infarction).
In the NARA-AKI cohort, types of surgery were originally divided into 4 categories (ie, intra-thoracic surgery, intra-abdominal surgery, pelvic or major joint surgery, and other types of surgery), and recategorized for the validation of SPARK index. Gynecological surgery, such as total hysterectomy, and orthopedic surgery, including knee or hip replacement, were classified as pelvic or major joint surgery. Other surgical procedures, including intra-thoracic and intra-abdominal surgical procedures as well as neurosurgery, were classified as general surgery.
Systolic and diastolic blood pressure were measured in the operation room before induction of anesthesia.
Incidence of AKI Stratified by SPARK Classes
| SPARK class | Total score | Participants, No. (%) | |
|---|---|---|---|
| Incidence of PO-AKI | Incidence of critical AKI | ||
| A | <20 | 10/593 (1.7) | 4/593 (0.7) |
| B | ≥20 to <40 | 119/2711 (4.4) | 67/2711 (2.5) |
| C | ≥40 to <60 | 121/1499 (8.1) | 43/1499 (2.9) |
| D | ≥60 | 53/332 (16.0) | 23/332 (6.9) |
Abbreviations: AKI, acute kidney injury; SPARK, Simple Postoperative AKI Risk; PO-AKI, postoperative acute kidney injury.
Figure 2. Receiver Operating Characteristic Curves and Calibration Plots for Postoperative Acute Kidney Injury (PO-AKI) and Critical AKI
AUC indicates area under the curve.
Regression Coefficients in the Proportional Odds Model
| Factor | Coefficient (95% CI) |
|---|---|
| Age, y (vs <40) | |
| ≥40 to <60 | 0.272 (−0.195 to 0.740) |
| ≥60 to <80 | 0.178 (−0.269 to 0.625) |
| ≥80 | 0.064 (−0.513 to 0.642) |
| Men (vs women) | 0.341 (0.098 to 0.584) |
| Diabetes (vs none) | 0.238 (−0.058 to 0.535) |
| Expected surgical duration (continuous, h) | 0.032 (−0.032 to 0.096) |
| Emergency surgery (vs planned) | 0.012 (−0.450 to 0.473) |
| RAAS blockade use (vs none) | 0.123 (−0.170 to 0.422) |
| eGFR (vs ≥60 mL/min/1.73 m2) | |
| ≥45 to <60 mL/min/1.73 m2 | 0.446 (0.099 to 0.794) |
| ≥30 to <45 mL/min/1.73 m2 | 1.143 (0.706 to 1.579) |
| ≥15 to <30 mL/min/1.73 m2 | 1.267 (0.699 60 1.835) |
| Anemia (vs none) | 0.399 (0.131 to 0.666) |
| Hypoalbuminemia (vs none) | 0.740 (0.399 to 1.081) |
| Hyponatremia (vs none) | 0.071 (−0.486 to 0.627) |
| Albuminuria (vs none) | 0.505 (0.173 to 0.836) |
Abbreviations: eGFR, estimated glomerular filtration rate; RAAS, renin-angiotensin-aldosterone system.
P < .05.